The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
<h4>Background</h4>Onchocerciasis ("river blindness") can cause severe morbidity, including vision loss and various skin manifestations, and is targeted for elimination using ivermectin mass drug administration (MDA). We calculated the number of people with Onchocerca volvulus...
Guardado en:
Autores principales: | Natalie V S Vinkeles Melchers, Wilma A Stolk, Welmoed van Loon, Belén Pedrique, Roel Bakker, Michele E Murdoch, Sake J de Vlas, Luc E Coffeng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b513b8d560024ee0a8ebb56d338e43fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Natalie V S Vinkeles Melchers, et al.
Publicado: (2021) -
African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
por: Luc E Coffeng, et al.
Publicado: (2013) -
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.
por: Méba Banla, et al.
Publicado: (2014) -
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning.
por: Elizabeth A Cromwell, et al.
Publicado: (2021) -
Ocular onchocerciasis: current management and future prospects
por: Babalola OE
Publicado: (2011)